
|Articles|February 1, 2004
No formulary should restrict itself to one SSRI for treatment of depression
Experts say SSRIs tend to have similar efficacy but different side effect profiles, and patients who don't respond to one might respond to another
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
TrumpRx launches; some experts question its long-term value
3
PBM reform. It has finally happened
4
What exactly is managed care today?
5























